MedTrace Logo

Evaluation of the Containment Impact Linked to the Covid-19 Pandemic in a Population of Parkinson Patients

NCT04466839 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 411

Last updated 2021-09-14

No results posted yet for this study

Summary

The consequences of COVID-19 in these already fragile patients should be evaluated. It will be important to appreciate the confinement consequences imposed on the patient on the course and impact of the disease.

These consequences can be assessed by the end of confinement and 6 months after the latter is lifted.

Conditions

  • Parkinson Disease
  • COVID

Interventions

OTHER

Questionnaire and interview

The questionnaires are Parkinson Disease Questionnaire-8 Items (PDQ-8) Visual Analog Scale (VAS) is visual analog scale visual numeric from 0 to 100, Neuropsychiatric Inventory-Questionnaire-Reduced (NPI-R) and Clinical Global Impression-Impairment (CGI-I).

Sponsors & Collaborators

  • University Hospital, Toulouse

    lead OTHER

Principal Investigators

  • Fabienne ORY MAGNE · University Hospital, Toulouse

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-02
Primary Completion
2020-12-18
Completion
2020-12-18

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04466839 on ClinicalTrials.gov